Sandra Cuéllar
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Stacy S. Shord (4 shared papers)Eric M. Tichy (8 shared papers)Matthew H Rim (8 shared papers)Mina Tadrous (7 shared papers)James M. Hoffman (8 shared papers)Glen T. Schumock (8 shared papers)John Spencer Clark (6 shared papers)Linda R. Bressler (1 shared paper)
- Journals
- American Journal of Health-System Pharmacy (10 papers)Journal of Clinical Oncology (2 papers)Journal of the American Pharmacists Association (2 papers)Annals of Pharmacotherapy (2 papers)BMC Women s Health (1 paper)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Sandra Cuéllar
29 papers receiving 463 citations
Peers
Comparison fields: 5 of 92
- Family Practice 34
- Geriatrics and Gerontology 28
- Hematology 37
- Oncology 77
- Genetics 29
Countries citing papers authored by Sandra Cuéllar
This map shows the geographic impact of Sandra Cuéllar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Cuéllar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Cuéllar more than expected).
Fields of papers citing papers by Sandra Cuéllar
This network shows the impact of papers produced by Sandra Cuéllar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Cuéllar. The network helps show where Sandra Cuéllar may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Cuéllar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 91 | |
| 2 | 2022 | 41 | |
| 3 | 2020 | 39 | |
| 4 | 2017 | 34 | |
| 5 | 2021 | 33 | |
| 6 | 2018 | 32 | |
| 7 | 2023 | 31 | |
| 8 | 2019 | 28 | |
| 9 | 2020 | 19 | |
| 10 | 2024 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2013 | 14 | |
| 13 | 2017 | 13 | |
| 14 | 2019 | 11 | |
| 15 | 2014 | 9 | |
| 16 | 2010 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2017 | 6 | |
| 19 | 2018 | 5 | |
| 20 | 2008 | 5 |
About Sandra Cuéllar
Sandra Cuéllar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Hematology and Economics and Econometrics, having authored 32 papers that have together received 474 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Pharmaceutical Economics and Policy (4 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), Erythropoietin and Anemia Treatment (3 papers), Medication Adherence and Compliance (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Mobile Health and mHealth Applications (2 papers). The work is most often cited by research in Family Practice (34 citations), Geriatrics and Gerontology (28 citations), Hematology (37 citations), Oncology (77 citations) and Genetics (29 citations). Sandra Cuéllar has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Stacy S. Shord, Eric M. Tichy, Matthew H Rim, Mina Tadrous, James M. Hoffman, Glen T. Schumock, John Spencer Clark, Linda R. Bressler, Katie J. Suda and Michelle D. Wiest. Their work appears in journals such as American Journal of Health-System Pharmacy, Journal of Clinical Oncology, Journal of the American Pharmacists Association, Annals of Pharmacotherapy and BMC Women s Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.